Cargando…

Oligometastasis and local ablation in the era of systemic targeted and immunotherapy

BACKGROUND: During these last years, new agents have dramatically improved the survival of the metastatic patients. Oligometastases represent a continuous field of interest in which the integration of metastases-directed therapy and drugs could further improve the oncologic outcomes. Herein a narrat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazzola, Rosario, Jereczek-Fossa, Barbara Alicja, Franceschini, Davide, Tubin, Slavisa, Filippi, Andrea Riccardo, Tolia, Maria, Lancia, Andrea, Minniti, Giuseppe, Corradini, Stefanie, Arcangeli, Stefano, Scorsetti, Marta, Alongi, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197157/ https://www.ncbi.nlm.nih.gov/pubmed/32366258 http://dx.doi.org/10.1186/s13014-020-01544-0

Ejemplares similares

Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic
por: Magrini, Stefano Maria, et al.
Publicado: (2020)

Adrenal oligometastasis cured with stereotactic ablative radiotherapy
por: Malone, Julia, et al.
Publicado: (2020)

Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system
por: Giaj-Levra, Niccolò, et al.
Publicado: (2019)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
por: Mazzola, Rosario, et al.
Publicado: (2019)

Diagnosis of oligometastasis
por: Terao, Mayako, et al.
Publicado: (2020)

Lung Radiofrequency Ablation: Potential as a Therapy to Oligometastasis and Oligorecurrence
por: Hiraki, Takao, et al.
Publicado: (2012)

Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique
por: Ruggieri, Ruggero, et al.
Publicado: (2018)

microRNAs and oligometastasis
por: Khodarev, Nikolai N., et al.
Publicado: (2015)

Stereotactic Radiotherapy for Oligometastasis
por: Otake, Sotaro, et al.
Publicado: (2019)

EUS-guided radiofrequency ablation for a left adrenal oligometastasis of an esophageal adenocarcinoma
por: Inderson, Akin, et al.
Publicado: (2018)

Oligometastasis: More Lessons to Be Learned
por: Kim, Kyung Hwan, et al.
Publicado: (2023)

MicroRNA Expression Characterizes Oligometastasis(es)
por: Lussier, Yves A., et al.
Publicado: (2011)

Metastasis-directed therapy for oligometastasis and beyond
por: Beckham, Thomas H., et al.
Publicado: (2020)

A Definitive IMRT-SIB with Concomitant Chemotherapy for Synchronous Locally Advanced Anal Canal Cancer and Prostate Cancer
por: Slavisa, Tubin, et al.
Publicado: (2018)

Oligometastasis: Expansion of Curative Treatments in the Field of Oncology
por: Lim, Ah Reum, et al.
Publicado: (2023)

A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study
por: Nicosia, Luca, et al.
Publicado: (2022)

Time-synchronized immune-guided SBRT partial bulky tumor irradiation targeting hypoxic segment while sparing the peritumoral immune microenvironment
por: Tubin, Slavisa, et al.
Publicado: (2019)

Oligometastasis and oligo-recurrence: more than a mirage
por: Huang, Fang, et al.
Publicado: (2014)

Barriers in Oligometastasis Care in Korea: Radiation Oncologists’ Perspectives
por: Chie, Eui Kyu, et al.
Publicado: (2023)

OLIGOMETASTASIS IN GASTRIC CANCER TREATMENT: IS THERE A PLACE FOR THE SURGEON?
por: de ASSUMPÇÃO, Paulo Pimentel, et al.
Publicado: (2023)

Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects
por: Tubin, Slavisa, et al.
Publicado: (2019)

Positron Emission Tomography–Derived Metrics Predict the Probability of Local Relapse After Oligometastasis-Directed Ablative Radiation Therapy
por: Greco, Carlo, et al.
Publicado: (2021)

Prognostic Utility of Histological Growth Patterns of Colorectal Lung Oligometastasis
por: Yeong, Son Jae, et al.
Publicado: (2018)

Revisiting a Null Hypothesis: Exploring the Parameters of Oligometastasis Treatment
por: Scarborough, Jessica A., et al.
Publicado: (2021)

Photodynamic therapy for treatment of recurrent adenocarcinoma of the lung with tracheal oligometastasis
por: Singh, Harpreet, et al.
Publicado: (2022)

A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group
por: Marvaso, Giulia, et al.
Publicado: (2023)

Late metastatic presentation is associated with improved survival and delayed wide‐spread progression after ablative stereotactic body radiotherapy for oligometastasis
por: Chen, Xuguang, et al.
Publicado: (2021)

Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance
por: Triggiani, Luca, et al.
Publicado: (2021)

MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer
por: Cuccia, Francesco, et al.
Publicado: (2021)

Altered fractionation in radiation therapy for breast cancer in the elderly: are we moving forward?
por: Pinzi, Valentina, et al.
Publicado: (2020)

Biology of NSCLC: Interplay between Cancer Cells, Radiation and Tumor Immune Microenvironment
por: Tubin, Slavisa, et al.
Publicado: (2021)

Knowing When to Use Stereotactic Ablative Radiation Therapy in Oligometastatic Cancer
por: Franceschini, Davide, et al.
Publicado: (2021)

Combined CT-guided radiofrequency ablation with systemic chemotherapy improves the survival for nasopharyngeal carcinoma with oligometastasis in liver: Propensity score matching analysis
por: Li, Wang, et al.
Publicado: (2016)

Surgical treatment in non-small cell lung cancer with pulmonary oligometastasis
por: He, Jinyuan, et al.
Publicado: (2017)

Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis
por: Poon, Ian, et al.
Publicado: (2020)

Percutaneous Polidocanol Injection as an Alternative Treatment in Differentiated Thyroid Cancer Oligometastasis
por: Alvarez Castillo, Marlen Alejandra, et al.
Publicado: (2021)

Role of Local Treatment for Oligometastasis: A Comparability-Based Meta-Analysis
por: Rim, Chai Hong, et al.
Publicado: (2022)

Reply to ‘Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’’
por: Triggiani, Luca, et al.
Publicado: (2018)

In reply to Simcock et al.
por: Magrini, Stefano Maria, et al.
Publicado: (2020)

Small cell lung cancer with thyroid gland oligometastasis: A case report
por: Tsutsui, Toshiharu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l6i0vm08g50o23j2dqufapnp9m